eyenovia-logo 3

SEC Filings

SEC Filings

Filing date Form Description Filing Group View
8-K

Report of unscheduled material events or corporate event

Current Reports
10-K

Annual report which provides a comprehensive overview of the company for the past year

Annual Filings
EX-101.INS - XBRL INSTANCE DOCUMENT
8-K

Report of unscheduled material events or corporate event

Current Reports
8-K

Report of unscheduled material events or corporate event

Current Reports
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

3,4,5
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

3,4,5
SC 13D

Filing by person(s) reporting owned shares of common stock in a public company >5%

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5
4

Statement of changes in beneficial ownership of securities

3,4,5

Contact us for more information

Contact us today to learn more about how our microdosing technology is poised to transform
the standard of care in ophthalmic therapeutic delivery.

295 Madison Ave., Suite 2400, New York, NY 10017     +1 (917) 289-1117

[email protected]